RxNorm Semantic Concepts Index - 612
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "612".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 612 | Algeldrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 612 | Algeldrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 612 | Algeldrate | Full form of descriptor (FN) | YES | |
| RxCUI: 612 | Algeldrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 612 | Algeldrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 612 | Algeldrate | Designated preferred name (PT) | YES | |
| RxCUI: 612 | Algeldrate | Designated preferred name (PT) | YES | |
| RxCUI: 612 | Algeldrate | Full form of descriptor (FN) | YES | |
| RxCUI: 6126 | Keratolytic agent | Designated preferred name (PT) | NO | |
| RxCUI: 6126 | Keratolytic agent | Full form of descriptor (FN) | NO | |
| RxCUI: 61280 | Hb 98(FG5), Val-gly | British preferred term (PTGB) | NO | |
| RxCUI: 61280 | Hb 98(FG5), Val-gly | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61280 | Hb 98(FG5), Val-gly | Designated preferred name (PT) | NO | |
| RxCUI: 61280 | Hb 98(FG5), Val-gly | Full form of descriptor (FN) | NO | |
| RxCUI: 612865 | tocilizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 612865 | tocilizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 612865 | tocilizumab | Designated preferred name (PT) | YES | |
| RxCUI: 612865 | tocilizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 612865 | tocilizumab | Designated preferred name (PT) | YES | |
| RxCUI: 6129 | Ketalar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 612937 | Interferon alfa-n3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 612937 | Interferon alfa-n3 | Designated preferred name (PT) | YES | |
| RxCUI: 612937 | Interferon alfa-n3 | Full form of descriptor (FN) | YES | |
| RxCUI: 612937 | Interferon alfa-n3 | Designated preferred name (PT) | YES | |
| RxCUI: 612937 | Interferon alfa-n3 | Full form of descriptor (FN) | YES |